About Us | Education | Resources & Publications | Consumer Info | Career | News Room | For Healthcare Providers | Members Only

Genetic Counseling in a New Era of Genetic Medicine: Mutation-Based Treatment

The NSGC Education Committee and Board of Directors are pleased to announce the online course, Genetic Counseling in a New Era of Genetic Medicine: Mutation-Based Treatment, co-sponsored by PTC Therapeutics, Inc. The 11-session webinar will explore ways in which genetic counselors may encounter genetic medicine now and in the near future, from drug development through genotyping, clinical trials and potential new treatments.

Objectives

After participating in Genetic Counseling in a New Era of Genetic Medicine, attendees will be able to:

  • Recognize the availability of current and future clinical trials for treatment of genetic diseases based on mutation type, and the necessity of genotyping for all patients.
  • Identify the principal aspects of therapeutic drug development and clinical trials.
  • Describe mechanism of action and primary clinical aspects of ataluren (formerly PTC124).
  • Discuss clinical utility, appropriate testing methodologies, and patient impact of current mutation-specific treatment trials as well as ongoing research for future therapies.

Course Format

Genetic Counseling in a New Era of Genetic Medicine consists of 11 pre-recorded presentations that include the presenter’s lecture, fully-synchronized to his or her slide presentation. All presentations will be posted online for access and review. Participants will be able to submit questions for a two-week period following the posting of each presentation and to receive an answer in writing from the presenter. At the end of that time, all the questions and answers will be posted.

Genetic Counseling in a New Era of Genetic Medicine offers a convenient format, allowing participants to listen to presentations on their own schedule, at any time of day. The format supports increased information retention through a self-directed process that allows participants to learn in their own time at their own pace.

Participants interested in earning CEUs for participation in the Genetic Counseling in a New Era of Genetic Medicine will be required to complete and pass a quiz for each session.

Presentation Availability

Genetic Counseling in a New Era of Genetic Medicine will be available beginning June 22, 2009. For instructions on how to access the presentations after completing your registration, please click here.

Access to the presentations will remain available to all registered participants through June 28, 2010. You can return to the presentations at any time during that year.

Presentations will be released into the online portal approximately every 3 weeks, beginning June 22, 2009 and ending December 28, 2009. Presentations will be posted on Mondays, and participants will be notified of the posting of each new presentation via e-mail. The agenda of topics and speakers is below. Please note: Presentation release dates are tentative and may be adjusted as necessary.

Accessing the Presentations

Once you purchase the activity, you will need to wait up to fifteen minutes for the server to enable access within your NSGC member record. While you are logged-in to the NSGC website, you will see a listing of all sessions contained in the package you purchased within the left-menu navigation (below your name). Please note: you may need to scroll down.

For complete instructions for online access, technical requirements and troubleshooting tips, please click here.

Presentation Titles, Speakers and Projected Release Dates

Date Title Speaker(s)
6/22/09 Overview of the Drug Discovery and Development Process Ellen Welch, PhD
(PTC Therapeutics, Inc.)
7/20/09 Ataluren Discovery and Mechanism of Action Stuart Peltz, PhD
(PTC Therapeutics, Inc.)
8/3/09 Developing the Evidence Base - Clinical Trial Design Langdon Miller, MD
(PTC Therapeutics, Inc.)
8/10/09 Evaluating the safety and efficacy of a mutation-based treatment for cystic fibrosis: Recruiting, Reporting, and Running the CF Ataluren trial Elinor Langfelder-Schwind, MS, CGC
(St. Vincents Catholic Medical Centers of New York)

Steve Rowe, MD
(University of Alabama at Birmingham)
8/24/09 Clinical Trials and the Genetic Counselor Meadow Heiman, MS, CGC
(Indiana Hemophilia and Thrombosis Center)
9/14/09 Why now? Patient Centered Registries as a Tool to Facilitate Research and Clinical Trials Vanessa Rangel Miller, MS, CGC
(Duchenne Connect Registry, Emory University School of Medicine)
10/5/09 I’ve got the perfect treatment – now what? Debra Lochner Doyle, MS, CGC
(University of Washington)

Wylie Burke, MD, PhD
(University of Washington)
10/26/2009 Therapeutic Relevance of Genotyping: What is the Difference? Matthew Deardorff, MD, PhD
(Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine)
11/16/09 Treating the Multi-Systemic effects of a Single Gene Disorder John Day, MD
(University of Minnesota)
12/7/09 Lessons from the experts: Duchenne and Becker Muscular Dystrophy W. Andrew Faucett
(Emory University School of Medicine)
12/28/09 Cystic Fibrosis: Clinical Update and Patient Perspectives Jeanne Weiland, RN, MSN, CPNP
(Children’s Hospital Medical Center, Cincinnati, OH)

Facilitated Questions and Answers

Speakers and/or Moderators will answer questions via e-mail for two weeks following the initial launch of the presentation online. Dates and e-mail addresses for submitting questions will be included as part of each slide presentation. Although Q and A is available only for a limited time, presentations will be available in their entirety for viewing and CEU credit through June 2010.

Registration Information and Fees

The registration fee includes access to all 11 pre-recorded lectures, the Q and A documents and glossaries. Partial access will not be granted.

Registration fees are as follows:

  • NSGC Member: $150 (includes CEU fee)
  • Non-Member: $185 (includes CEU fee)

To register, please click here. Please note that you must be logged into the NSGC Website to receive the member rate. Credit cards are the only method of payment accepted. If you have any questions concerning registration, please contact nsgc@nsgc.org.

Once you purchase the activity, you will need to wait up to fifteen minutes for the server to enable access within your NSGC member record. While you are logged-in to the NSGC website, you will see a listing of all sessions contained in the package you purchased within the left-menu navigation (below your name). Click on the course title to be directed to the online learning portal. Note: you may need to scroll down.

CEUs

This activity has been submitted to the National Society for Genetic Counselors (NSGC) for approval of 1.55 Category 1 CEUs (15.5 contact hours). The American Board of Genetic Counseling accepts CEUs approved by NSGC for purposes of recertification. Approval for the requested CEUs and contact hours is currently pending.

Participants interested in earning CEUs for participation in the webinar will be required to complete and pass a quiz for each session. Participants have three options:

  • Complete all the modules by December 31, 2009 for credit in 2009
  • Complete all the modules by June 28, 2010 for credit in 2010
  • Divide the modules and receive some CEUs in each year

Back to Online Education Main Page

 

 

0